Themis Bioscience and CEPI Announce Initiation of Phase 1 Clinical Trial with Lassa Fever Vaccine | Vaccines | News Channels - PipelineReview.com

Themis Bioscience and CEPI Announce Initiation of Phase 1 Clinical Trial with Lassa Fever Vaccine | Vaccines | News Channels  PipelineReview.com